APOE and Cognitive impairment: This analysis incorporated plasma pTau217, pTau181, ratio Aβ1–42/ Aβ1–40, Age, Sex, APOE ε4 allele presence, and clinical diagnosis group (cognitively unimpaired, mild cognitive impairment, and dementia).